Cryoport Inc.: BTIG sees 67% Upside Potential - Market Outlook for Cell and Gene Therapies Improves
Reading Time: 2 minutes
Cryoport Inc. (CYRX) is a global provider of temperature-controlled supply chain solutions for the life sciences. Fundamentally, the company recently reported robust quarterly results on August 5. Today, the stock has again made it to the list of the top 10 price targets from analysts following a positive report. Robust Fundamentals Cryoport Inc. (CYRX) announced its financial results for the second quarter of 2025 on August 5. The company reported a revenue increase of 14% compared to the previous year, reaching $45.5 million. Revenues from...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
